ADAPTIVE RESISTANCE TO NITRIC OXIDE
对一氧化氮的适应性抵抗
基本信息
- 批准号:7093262
- 负责人:
- 金额:$ 3.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-17 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Nitric oxide (NO) is produced in mammalian cells by several NO synthases, including an inducible form with high output during inflammation. Since NO may contribute to carcinogenesis and age- related neurodegeneration, we wish to understand how mammalian cells counteract NO toxicity. We have identified a group of 12 proteins induced in normal human fibroblasts by exposure to subtoxic levels of NO, including the antioxidant enzyme heme oxygenase 1 (HO-1). We have shown that the induction of HO-1 mRNA occurs via NO-dependent changes in its stability. We will explore the mechanism of this regulation and try to define the signal transduction pathway for post-transcriptional control of HO-1. Other genes (e.g., MAP kinase phosphatase MKP-1/CL100) are controlled transcriptionally, and we will test specific transcription regulators for their roles in this expression. We have identified an adaptive resistance to NO in the rodent motor neurons: cells exposed to low-level NO that induces HO-1 become resistant to much higher (usually cytotoxic) levels of NO. We will characterize this response in various cell types by identifying NO-inducible genes and determining their roles in protection against NO-mediated toxicity. HO-1 knockout mice will allow us to define the defensive role of HO-1 in fibroblasts, neurons, and other tissues. This project involves parallel efforts to follow biochemical markers of nitric oxide damage (e.g., nitrotyrosine), to use genetics to establish the role of HO-1 in inducible resistance to NO, to elucidate regulatory and signal transduction pathways, and to identify and clone novel defense genes for NO resistance.
在哺乳动物细胞中,一氧化氮(NO)是由几种NO合成酶产生的,包括炎症期间高输出的诱导形式。由于NO可能有助于致癌和年龄相关的神经退行性变,我们希望了解哺乳动物细胞如何抵抗NO毒性。我们鉴定了暴露于亚毒性水平NO的正常人成纤维细胞中诱导的一组12种蛋白质,包括抗氧化酶血红素加氧酶1 (HO-1)。我们已经证明,HO-1 mRNA的诱导是通过no依赖性的稳定性变化发生的。我们将探索这种调控的机制,并试图确定HO-1转录后调控的信号转导途径。其他基因(如MAP激酶磷酸酶MKP-1/CL100)受转录控制,我们将测试特定的转录调节因子在这种表达中的作用。我们已经确定了啮齿动物运动神经元对NO的适应性抗性:暴露于诱导HO-1的低水平NO的细胞对更高(通常是细胞毒性)水平的NO产生抗性。我们将通过鉴定no诱导基因并确定其在no介导的毒性保护中的作用来表征各种细胞类型中的这种反应。HO-1敲除小鼠将使我们能够确定HO-1在成纤维细胞、神经元和其他组织中的防御作用。该项目包括跟踪一氧化氮损伤的生化标记(如硝基酪氨酸),利用遗传学确定HO-1在诱导抵抗NO中的作用,阐明调控和信号转导途径,并鉴定和克隆新的NO抗性防御基因。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Resistance to nitric oxide-induced necrosis in heme oxygenase-1 overexpressing pulmonary epithelial cells associated with decreased lipid peroxidation.
血红素加氧酶-1 过表达肺上皮细胞对一氧化氮诱导的坏死的抵抗力与脂质过氧化减少相关。
- DOI:10.1074/jbc.m602634200
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Reiter,TiffanyA;Pang,Bo;Dedon,Peter;Demple,Bruce
- 通讯作者:Demple,Bruce
Carbon monoxide mediates protection against nitric oxide toxicity in HeLa cells.
- DOI:10.1016/j.freeradbiomed.2005.05.023
- 发表时间:2005-10
- 期刊:
- 影响因子:7.4
- 作者:Tiffany A. Reiter;B. Demple
- 通讯作者:Tiffany A. Reiter;B. Demple
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce F. Demple其他文献
Bruce F. Demple的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce F. Demple', 18)}}的其他基金
Single- and multinucleotide base excision DNA repair pathways in vivo
体内单核苷酸和多核苷酸碱基切除 DNA 修复途径
- 批准号:
8959001 - 财政年份:2015
- 资助金额:
$ 3.65万 - 项目类别:
Single- and multinucleotide base excision DNA repair pathways in vivo
体内单核苷酸和多核苷酸碱基切除 DNA 修复途径
- 批准号:
9115558 - 财政年份:2015
- 资助金额:
$ 3.65万 - 项目类别:
相似海外基金
Vascular Mechanisms of Dementia: Cell-Type Specific Therapeutic and Imaging Strategies
痴呆症的血管机制:细胞类型特异性治疗和成像策略
- 批准号:
10523230 - 财政年份:2022
- 资助金额:
$ 3.65万 - 项目类别:














{{item.name}}会员




